Low serum cholesterol and the risk of cerebral haemorrhage

Atherosclerosis

Volumn 119, Issue 1, 1996, Pages 1-6

  Puddey, Ian B ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cerebral haemorrhage; Lipid lowering therapy; Serum cholesterol

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL;

BRAIN HEMORRHAGE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MORTALITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STROKE;

EID: 0030050630     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(95)05634-3     Document Type: Review

References (35)

1. Law MR, Thompson SG, Wald NJ. Assessing possible hazards of reducing serum cholesterol. Br Med J 1994;308:373.
2. Lin CH, Shimuzu Y, Kato H, Robertson TL, Furonaka H Kodama K, Fukunaga Y. Cerebrovascular diseases in a fixed population of Hiroshima and Nagasaki, with special reference to relationship between type and risk factors. Stroke 1984;15:653.
3. Okada H, Horibe H, Ohno Y, Hayakawa N, Aoki N. A prospective study of cerebrovascular disease in Japanese rural communities, Akabane and Asahi. I. Evaluation of risk factors in the occurrence of cerebral haemorrhage and thrombosis. Stroke 1976;7:599.
4. Yano K, Reed DM, MacLean CJ. Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program. Stroke 1989;20:1460.
5. Reed DM. The paradox of high risk of stroke in populations with low risk of coronary heart disease. Am J Epidemiol 1990;131:579.
6. Konishi M, Iso H, Komachi Y, lida M, Shimamoto T Jacobs DR Jr, Baba S, Sankai T, Ito M. Associations of serum total cholesterol, different types of stroke, and stenosis distribution of cerebral arteries. The Akita Pathology Study. Stroke 1993;24:954.
7. Gordon T, Kannel WB, Castelli WP, Dawber TR. Lipoproteins, cardiovascular disease, and death. The Framingham Study. Arch Int Med 1981;141:1128.
8. Iso H, Jacobs DR, Wentworth D, Neaton JD, Cohen JD. Serum cholesterol levels and six year mortality from stroke in 350 977 men screened for the multiple risk factor intervention trial. New Engl J Med 1989;320:904.
9. Dyer AR, Stamler J, Paul O, Shekelle OB, Schoenberg JA Berkson DM. Serum cholesterol and risk of death from cancer and other causes in three Chicago epidemiologic studies. J Chron Dis 1989;34:249.
10. Lindenstrom E, Boysen G, Nyboe J. Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: The Copenhagen city heart study. Br Med J 1994;309:11.
11. Gatchev O, Rastam L, Lindberg G, Gullberg B, Eklund GA, Isacsson SO. Subarachnoid hemorrhage, cerebral hemorrhage and serum cholesterol concentration in men and women. Ann Epidemiology 1993;3:403.
12. Atkins D, Psaty BM, Koepsell TD, Longstreth WT, Larson EB. Cholesterol reduction and the risk for stroke in men. A meta-analysis of randomized, controlled trials. Ann Int Med 1993;119:136.
13. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P Helo PN. Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidaemia. New Engl J Med 1987;317:1237.
14. Hebert PR, Gaziano JM, Hennekens CH. An overview of cholesterol lowering and risk of stroke. Arch Int Med 1995;155:50.
15. Yamori Y, Horie R, Ohtaka M, Nara Y, Fukase M. Effect of hypercholesterolaemic diet on the incidence of cerebrovascular and myocardial lesions in spontaneously hypertensive rats (SHR). Clin Exp Pharmacol Physiol 1976;3(Suppl):205.
16. Fletcher A, Alkjaersig N, Schonfeld G, Witztum J. Fibrinogen catabolism in patients with Type II and Type IV hyperlipidaemia. Arteriosclerosis 1981;1:202.
17. Branchi A, Rovellini A, Sommariva D, Gugliandolo AG Fasoli A. Effect of three fibrate derivatives and of two HMG-CoA reductase inhibitors on plasma fibrinogen level in patients with primary hypercholesterolaemia. Thromb Haemost 1993;70:241.
18. Pazzucconi F, Mannucci L, Gianfranceschi G, Maderna P Werber P, Franceschini G, Sirtori CR, Temoli E. Bezafibrate lowers plasma lipids, fibrinogen and platelet aggregation in hypertriglyceridaemia. Eur J Clin Pharmacol 1992;43:219.
19. Chen Z, Peto R, Collins R, MacMahon S, Lu J, Li W. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. Br Med J 1991;303:276.
20. Harmsen P, Rosengren A, Tsipogianni A, Wilhelmsen L. Risk factors for stroke in middle-aged men in Goteborg, Sweden. Stroke 1990;21:223.
21. Haheim LL, Holme I, Hjermann I, Leren P. Risk factors of stroke incidence and mortality. A 12-year follow-up of the Oslo Study. Stroke 1993;24:1484.
22. Tilvis RS, Erkinjuntti T, Sulkava R, Farkkila M Miettinen TA. Serum lipids and fatty acids in ischemic strokes. Am Heart J 1987;113:615.
23. Lindgren A, Nilsson-Ehle P, Norrving B, Johansson BB. Plasma lipids and lipoproteins in subtypes of stroke. Acta Neurol Scand 1992;86:572.
24. Sridharan R. Risk factors for ischemic stroke: a case control analysis. Neuroepidemiology 1992;11:24.
25. Woo J, Lau E, Lam CW, Kay R, Teoh R, Wong HY, Prall WY, Kreel L. Hypertension, lipoprotein(a), and apolipoprotein A-I as risk factors for stroke in the Chinese. Stroke 1991;22:203.
26. Aronow WS, Ahn C. Correlation of serum lipids with the presence or absence of atherothrombotic brain infarction and peripheral arterial disease in 1834 men and women aged > 62 years. Am J Cardiol 1994;73:995.
27. Woo J, Lam CW, Kay R, Wong HY, Teoh R, Nicholls MG. Acute and long-term changes in serum lipids after acute stroke. Stroke 1990;21:1407.
28. Qizilbash N, Jones L, Warlow C, Mann J. Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischaemic strokes. Br Med J 1991;303;605.
29. Homer D, Ingall TJ, Baker HL, O'Fallon WM, Kottke BA Whisnant JP. Serum lipids and lipoproteins are less powerful predictors of extracranial carotid atherosclerosis than are cigarette smoking and hypertension. Mayo Clinic Proc 1991;66:259.
30. Palomaki H, Kaste M, Raininko R, Salonen O, Juvela S Sarna S. Risk factors for cervical atherosclerosis in patients with transient ischemic attack or minor ischemic stroke. Stroke 1993;24:970.
31. Szirmai IG, Kamondi A, Magyar H, Juhasz C. Relation of laboratory and clinical variables to the grade of carotid atherosclerosis. Stroke 1993;24:1811.
32. Prati P, Vanuzzo D, Casaroli M, Di Chiara A, De Biasi F, Feruglio GA. Prevalence and determinants of carotid atherosclerosis in a general population. Stroke 1992;23:1705.
33. The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383.
34. Pedro-Botet J, Senti M, Nogues X, Rubies-Prat J Roquer J, Olive J. Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceriderich lipoproteins, and apolipoprotein E polymorphism. Stroke 1992;23:1556.
35. Lovostatin Study Groups I-IV: Lovostatin 5-year safety and efficacy study. Arch Intern Med 1993;153:1079.